Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	1.56	45.35	44.66
Graham Fair Price	-20.71	9.17	11.57
PEG	13.52	-0.80	-0.92
Price/Book	-12.65	2.50	2.86
Price/Cash Flow	541.46	395.23	-61.61
Prices/Earnings	20.66	25.33	20.99
Price/Sales	-17.45	10.99	13.31
Price/FCF	541.46	395.23	-61.61
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-10.50	0.39	0.43
Operating Margin	-21.45	0.15	0.19
ROA	-34.54	0.01	0.02
ROE	0.03	0.02	-27.61
ROIC	0.02	0.02	-24.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.31	0.13	137.93
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.23	-0.23	0.76
EPS QOQ	-0.23	-0.32	-39.51
FCF QOQ	-2.34	1.13	-51.96
Revenue QOQ	-0.11	-0.02	82.45
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	185.31	177.90	-4.00
Days Sales Outstanding (DSO)	46.75	53.47	14.38
Inventory Turnover	0.49	0.51	4.16
Debt/Capitalization	0.25	0.31	24.25
Quick Ratio	0.86	0.83	-3.18
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	13.22	12.32	-6.80
Cash	2.08	1.99	-4.27
Capex	-0.50	-0.50	0.87
Free Cash Flow	-0.61	0.08	-87.31
Revenue	2.84	2.80	-1.39
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.84	1.80	-2.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.48	5.71	64.19
Naive Interpretation	Member

06 - Financial Health · Weak

Rating